Betta Pharmaceuticals Co Ltd (300558) — Strategic Asset Allocation Index
Betta Pharmaceuticals Co Ltd (300558) has a Strategic Asset Allocation Index of 44.7% as of June 2023. Strategic assets (PP&E of CN¥2.30 Billion plus long-term investments of CN¥-) total CN¥2.30 Billion, measured against net assets of CN¥5.16 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Betta Pharmaceuticals Co Ltd Strategic Asset Allocation Index (2011–2021)
This chart shows how Betta Pharmaceuticals Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2011 to 2021. As of June 2023, the index stands at 44.7%, representing strategic assets of CN¥2.30 Billion against net assets of CN¥5.16 Billion CNY. Explore Betta Pharmaceuticals Co Ltd cash conversion from operations to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Betta Pharmaceuticals Co Ltd (2011–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Betta Pharmaceuticals Co Ltd from 2011 to 2021, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Betta Pharmaceuticals Co Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 28.4% | CN¥1.33 Billion | CN¥1.33 Billion | CN¥- | CN¥4.69 Billion | ▲ +9.7 pp |
| 2020 | 18.7% | CN¥775.72 Million | CN¥775.72 Million | CN¥- | CN¥4.14 Billion | ▼ -13.3 pp |
| 2019 | 32.0% | CN¥789.92 Million | CN¥789.92 Million | CN¥- | CN¥2.47 Billion | ▼ -8.2 pp |
| 2018 | 40.1% | CN¥900.94 Million | CN¥815.09 Million | CN¥85.85 Million | CN¥2.24 Billion | ▼ -9.0 pp |
| 2017 | 49.1% | CN¥1.02 Billion | CN¥863.15 Million | CN¥152.26 Million | CN¥2.07 Billion | ▲ +12.8 pp |
| 2016 | 36.4% | CN¥701.35 Million | CN¥558.18 Million | CN¥143.17 Million | CN¥1.93 Billion | ▼ -8.9 pp |
| 2015 | 45.3% | CN¥404.98 Million | CN¥274.67 Million | CN¥130.31 Million | CN¥893.95 Million | ▲ +16.7 pp |
| 2014 | 28.6% | CN¥155.15 Million | CN¥155.15 Million | CN¥- | CN¥543.03 Million | ▼ -1.7 pp |
| 2013 | 30.3% | CN¥96.72 Million | CN¥96.72 Million | CN¥- | CN¥319.10 Million | ▼ -16.8 pp |
| 2012 | 47.1% | CN¥81.25 Million | CN¥81.25 Million | CN¥- | CN¥172.56 Million | ▼ -105.8 pp |
| 2011 | 152.8% | CN¥79.90 Million | CN¥79.90 Million | CN¥- | CN¥52.28 Million | — |